Friday, November 21, 2008 - 3:53PM EST

Stem Cell Transplantation

1. Impact of age and serum creatinine value on outcome after autologous blood stem cell transplantation for patients with multiple myeloma.

Author
Gertz MA; Lacy MQ; Dispenzieri A; Hayman SR; Kumar S; Leung N; Gastineau DA;
Institution
1Division of Hematology, Mayo Clinic, Rochester, MN, USA.
Journal
Bone Marrow Transplant. 2007 May;39(10):605-11. Epub 2007 Mar 19.
Abstract URL
Click here to view abstract

2. Early relapses do not impact survival after autologous stem cell transplantation in African Americans with multiple myeloma.

Author
Khaled Y; Kato K; Janakiraman N; Ferrara JL; Mineishi S;
Institution
1Blood and Marrow Transplant Program, University of Michigan, Ann Arbor, MI, USA.
Journal
Bone Marrow Transplant. 2007 Jun;39(11):727-8. Epub 2007 Apr 2.

3. Targeted therapeutics for multiple myeloma: the arrival of a risk-stratified approach.

Author
Fonseca R; Stewart AK;
Institution
Mayo Clinic, 13208 East Shea Boulevard, Collaborative Research Building 3-006, Scottsdale, AZ 85259-5494, USA. fonseca.rafael@mayo.edu
Journal
Mol Cancer Ther. 2007 Mar;6(3):802-10.
Abstract URL
Click here to view abstract

4. Simple variables predict survival after autologous transplantation: a single centre experience in 181 multiple myeloma patients.

Author
Krejci M; Hajek R; Buchler T; Krivanova A; Svobodnik A; Pour L; Adam Z; Mayer J; Vorlicek J;
Institution
Journal
Neoplasma. 2007;54(2):143-8.
Abstract URL
Click here to view abstract

5. Peg-filgrastim versus filgrastim after autologous stem cell tranplantation: Case-control study in patients with multiple myeloma and review of the literature.

Author
Musto P; Scalzulli PR; Terruzzi E; Rossini F; Iacopino P; Messina G; Guariglia R; Pietrantuono G; Villani O; D'Auria F; Falcone A; Sanpaolo G; Valvano MR; Pogliani EM; Morabito F;
Institution
Unit of Haematology and Stem Cell Transplantation, CROB, "Centro di Riferimento Oncologico di Basilicata", Strada Provinciale, 8, 85028 Rionero in Vulture (Pz), Italy.
Journal
Leuk Res. 2007 Feb 22;.
Abstract URL
Click here to view abstract

6. Unrelated donor haematopoietic cell transplantation after non-myeloablative conditioning for patients with high-risk multiple myeloma.

Author
Bruno B; Sorasio R; Patriarca F; Montefusco V; Guidi S; Busca A; Scime R; Console G; Milone G; Marotta G; Dominietto A; Giaccone L; Rotta M; Falda M; Bacigalupo A; Bosi A; Corradini P; Fanin R; Pollichieni S; Boccadoro M;
Institution
Division of Hematology at the San Giovanni Battista Hospital, University of Torino, Torino, Italy. benedetto.bruno@unito.it
Journal
Eur J Haematol. 2007 Apr;78(4):330-7. Epub 2007 Feb 27.
Abstract URL
Click here to view abstract

7. Feasibility and safety of autotransplants with noncryopreserved marrow or peripheral blood stem cells: a systematic review.

Author
Wannesson L; Panzarella T; Mikhael J; Keating A;
Institution
Department of Medical Oncology and Hematology.
Journal
Ann Oncol. 2007 Apr;18(4):623-32. Epub 2007 Mar 12.
Abstract URL
Click here to view abstract

8. Symptom burden in patients undergoing autologous stem-cell transplantation.

Author
Anderson KO; Giralt SA; Mendoza TR; Brown JO; Neumann JL; Mobley GM; Wang XS; Cleeland CS;
Institution
1Department of Symptom Research, The University of Texas M. D. Anderson Cancer Center, Houston, TX, USA.
Journal
Bone Marrow Transplant. 2007 Apr 16;.
Abstract URL
Click here to view abstract

9. Limited feasibility of double transplant in multiple myeloma: results of a multicenter study on 153 patients aged <65 years.

Author
Corso A; Mangiacavalli S; Barbarano L; Alessandrino EP; Cairoli R; Morra E; Lazzarino M;
Institution
Division of Hematology, IRCCS Fondazione Policlinico San Matteo University of Pavia, Pavia, Italy.
Journal
Cancer. 2007 Apr 17;.
Abstract URL
Click here to view abstract

10. Results of a retrospective single institution analysis of targeted skeletal radiotherapy with (166)Holmium-DOTMP as conditioning regimen for autologous stem cell transplant for patients with multiple myeloma. Impact on transplant outcomes.

Author
Christoforidou AV; Saliba RM; Williams P; Qazilbash M; Roden L; Aleman A; Weber D; Mendoza F; Podoloff D; Wendt R 3rd; Breitz H; Alexanian R; Champlin R; Giralt S;
Institution
Department of Blood and Marrow Transplantation, University of Texas M.D. Anderson Cancer Center, Houston, Texas 77030, USA.
Journal
Biol Blood Marrow Transplant. 2007 May;13(5):543-9. Epub 2007 Feb 26.
Abstract URL
Click here to view abstract
Pages: 1 2